Alnylam Pharmaceuticals Inc at Needham Healthcare Conference Transcript
All right. Good morning, everyone. This is Alan Carr. I am a biotech research analyst here at Needham. Welcome to the 19th Annual Needham Healthcare Conference. This is our first virtual health care conference. Sorry for the slight technical delay, but we're off and running now. So with me, I have Barry Greene, President of Alnylam. Good morning, Barry. How are you?
Good morning, Alan. I appreciate you and Needham having us here today.
Questions & Answers
I am Glad you could join us. So we've got a few topics that we want to run through until 9:15 this morning. Let's start off with yesterday's news. I guess if you -- you did spend a call on it yesterday. So -- but I do want to give you just a minute or so to give us an update on the Blackstone financing and then maybe we can run through some of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |